The cell-surface receptor c-kit and its cognate ligand stemcell factor (SCFI or steel factor (SLF) are important for the maintenance of hematopoiesis both in vitro and in vivo. Transforming growth factor-beta (TGF-0) has been shown t o be a potent inhibitor of SLF-mediated synergistic growth of murine Lin-Sca-l' progenitor cells, as well as more committed progenitors. In the present study, we examined the regulation of c-kit mRNA and cell-surface expression by TGF-P. Among the murine hematopoietic progenitor cells tested, the myeloid cell line FDC-P1 and the mast-cell line MC-6, as well as progenitor-enriched bone marrow cells, constitutively expressed functional cell-surface c-kit. Treatment of these progenitor cell lines and primary progenitor cells with TGF-P resulted in downregulation of cell-surface c-kit expression. This effect was not a secondary event of cell-cycle HE PROTO-ONCOGENE c-kit encodes a transmembrane tyrosine kinase receptor that plays a critical role in hematopoiesis. This has been well illustrated by several lines of evidence. For example, mouse strains that carry the dominant White Spotting (W) locus that maps to c-kit are defective in the production of stem cells, resulting in severe anemia and mast-cell deficiency.',' In addition, the in vivo administration of antibodies to c-kit, which block ligand binding, results in impaired hematopoietic development. (m0(m6-4971/94/8311-0030$3.00/0 3138 status. TGF-P inhibition was dose-and time-dependent, with 5040 inhibition seen between 0.3 t o 3 ng/mL TGF-P and maximal inhibition at 30 ng/mL. Using the FDC-P1 cell line, we observed that the inhibition of cell-surface c-kit expression by TGF-P is preceded by a marked reduction in c-kit mRNA levels starting 2 hours after TGF-/.3 treatment, and reaches a maximum by 6 hours. The inhibition in steadystate c-kit mRNA levels is explained, in part, by a decrease in the half-life of c-kit transcripts (2 t o 4 hours for control cells v 0.5 t o 1.5 hours for TGF-P-treated cells). These findings suggest that TGF-P regulates the responsiveness of murine hematopoietic progenitors t o SLF through a decrease in c-kit message stability leading t o decreased cell-surface expression.
status. TGF-P inhibition was dose-and time-dependent, with 5040 inhibition seen between 0.3 t o 3 ng/mL TGF-P and maximal inhibition at 30 ng/mL. Using the FDC-P1 cell line, we observed that the inhibition of cell-surface c-kit expression by TGF-P is preceded by a marked reduction in c-kit mRNA levels starting 2 hours after TGF-/.3 treatment, and reaches a maximum by 6 hours. The inhibition in steadystate c-kit mRNA levels is explained, in part, by a decrease in the half-life of c-kit transcripts (2 t o 4 hours for control cells v 0.5 t o 1.5 hours for TGF-P-treated cells). These findings suggest that TGF-P regulates the responsiveness of murine hematopoietic progenitors t o SLF through a decrease in c-kit message stability leading t o decreased cell-surface expression. The growth of hematopoietic progenitors is also regulated by soluble negative regulators such as macrophage inflammatory protein-la (MIP-la), tumor necrosis factor-a (TNFa), interferon-y (IFN-y), and transforming growth factor$ (TGF-P), which are produced at the site of active hematopoiesis. 15 Among the negative regulators, TGF-P is a direct and selective inhibitor of the proliferation of primitive progenitors both in vitro and in vivo. '5"8 In particular, it inhibits the growth of both high proliferative potential colony-forming cells (HPP-CFC), which respond to a combination of SLF plus colony-stimulating factors (CSFs), and lin-SCA-l" cells, which respond to the combination of SLF plus interleukin-3 (IL-3)'' TGF-/3 has also been shown to inhibit the proliferation of IL-3 -dependent myeloid and mast-cell lines.'" Because c-kit and its ligand are central to the survival, growth, and differentiation of early hematopoietic progenitors, regulators of c-kir expression can have profound effects on hematopoiesis. We have previously shown that TGF-P regulates the cell-surface expression of colony-stimulating growth factor receptor expression." In this report, we provide evidence that TGF-P downregulates the expression of c-kit gene and its cell-surface product partly by reducing the stability of c-kit mRNA. The relevance of these findings to steady-state hematopoiesis is discussed.
TGF-8 INHIBITS c-kit EXPRESSION
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responsive mastocytoma cell line MC-6 was obtained from Immunex. The murine IL-3-dependent myeloid cell lines FDC-P1 and 32D-cl13 were derived from long-term bone marrow culture^."^^^ DA-3, NFS-60, and NFS-58 were derived from the spleens of mice infected with murine leukemia viruses.26 The cell lines have the characteristic of immature hematopoietic progenitors as determined by morphology, cytochemistry, and cell-surface marker expression.
Pur$cation of lin-bone marrow cells. Murine bone marrow cells were aspirated from BALB/c mouse femurs and light-density mononuclear cells were isolated by separation on Lymphocyte Separation Medium (Organon Teknika, Durham, NC). The lin-cells were selected using previously reported technique~.''~~~ Briefly, 0.5 pg/l x IO6 cells of antibodies RB6-8C5 (GR-l antigen), RA3-6B2 (B220 antigen) (gifts of Dr R. Coffman, DNAX, Palo Alto, CA); MAC-1 (purchased from Boehringer-Mannheim. Indianapolis, IN); Lyt-2 (CD8) and L3T4 (CD4) (purchased from Becton Dickinson, Sunnyvale, CA) were added to fractionated bone marrow cells and incubated for 30 minutes at 4°C in RPMI supplemented with 10% fetal calf serum (FCS). The cells are then washed twice, centrifuged, and resuspended in medium to a density of 1 X 10' cells/mL. Magnetic beads (Dynal, Great Neck, NY) were added to the cell suspension at a bead to target-cell ratio of 40:l and incubated 30 minutes at 4°C with constant rotation. The cells were then magnetically separated with a magnetic particle concentrator (Dynal) and the lin-cells obtained were washed, resuspended in Iscove's modified Dulbecco's medium (IMDM) and 10% FCS, and incubated at 2 X lo6 cells in the presence or absence of growth factors.
Preparation of radioiodinated SLF. Murine recombinant SLF was labeled with "'I using chloramine-T reagent as previously described." The radiolabeled SLF had a specific activity that ranged from 1 to 3 X 10" cpm/mmol.
Receptor binding assay. Light-density bone marrow cells and lin-cell suspensions were washed once with cold medium and the cell pellet was treated for 1 minute on ice with 50 mmoVL glycine-HC1 (pH 3) to remove bound cytokines. Subsequently, the cells were washed twice with binding medium (RPMI 1% bovine serum albumin [BSA] supplemented with 0.1% sodium azide and 10 mmoY L Hepes) and incubated at 4°C with 500 p m o a 1Z51-labeled SLF in a final volume of 0.2 mL. After 2 to 3 hours of incubation at 4"C, cell-bound radioactivity was separated from unbound Iz5I-SLF by centrifugation of the sample through a mixture of 1.5:l (voVvo1) dibutyl phthalatelbis (2-ethylhexyl) Cell proliferation assay. The cell lines were washed twice in serum-free RPMI 1640 and plated into 96-well microliter plates at a density of S X IO4 cells/mL of RPMI 10% FBS supplemented with 5 X molL 2-mercaptoethanol. Cultures were incubated for 48 hours at 37°C in 5% COz. Cell proliferation was then assessed with a 6-hour pulse with 1 pCi 3[H]thymidine (6.7 Ci/mmol; New England Nuclear, Boston, MA). Cell cultures were harvested with a multiple-sample harvester onto glass-fiber filters, and radioactivity was assessed by liquid scintillation counting.
RNA extraction and Northern blot analysis. After the appropriate treatments, as indicated in the figure legends, the cells were pelleted and total cellular RNA was isolated by acid guanidium thiocyanate-phenol-chlorophorm extraction according to Chomczynski and Sa~chi.'~ RNA was separated by electrophoresis on 1% agarose and transferred onto a Hybond-N (Amersham, Oakville, Canada) membrane for Northern analysis. Membranes were prehybridized for 4 hours in a mixture containing Tris 120 mmofi, EDTA 8 mmoVL, sodium pyrophosphate/O.l%, sodium dodecyl sulfate (SDS) 0.2%, and heparin 100 pg/mL. Hybridization was performed overnight at 68°C in prehybridization buffer containing 625 pg/mL heparin and 10% dextran sulfate. The murine c-kit probe was a 3,710-bp EcoRI-HindIII insert of the c-kit cDNA clone pGEM3 cKit3. The probe was further fragmented with DraI-Ad, and the fragments were labeled with multiprime DNA labeling system (Amersham), using (aP3')dCTF' (specific activity >3,000 Ci/mmoVL; Amersham). The membranes were then washed once at room temperature for 20 minutes in 2~ SSC, and l x SSC 0.1% SDS at 68°C for 60 minutes, then rinsed at room temperature with 0.1 X SSC. The membranes were exposed to Kodak XAR-5 film with intensifying screens at -80°C. As a control for RNA integrity, blots were rehybridized with a l-kb PstI cDNA probe (ATCC, Rockville, MD) of the housekeeping gene glyceraldehyde phosphate dehydrogenase (GAPDH).
Analysis of mRNA half-life. To assess stability of c-kit mRNA, FDC-P1 cells were incubated for 6 hours with medium or 20 ng/ mL TGF-P. Actinomycin D (S pg/mL; Sigma, St Louis, MO) was then added to arrest transcription, and total mRNA was prepared at the indicated times. Northern blot analysis was performed as describe earlier. Signal intensity was quantified by densitometry and normalized for GAPDH transcripts. An arbitrary value of 100% was assigned to the mRNA level of untreated and TGF-P-treated cells after 6 hours of incubation, ie, at time 0 of actinomycin D treatment.
RESULTS
Cell-su$ace c-kit expression in murine hematopoietic cell lines. Using radiolabeled SLF as a probe, we first screened several murine progenitor cell lines for the expression of cell-surface c-kit. Among the factor-dependent and -independent cell lines examined, the IL-3-dependent myeloid cell lines NFS-60 and FDC-PI, and the pro-mast-cell line MC-6 were positive for c-kit expression (Table 1) . Data from fluorescence-activated cell sorter (FACS) analysis of the cell lines stained with MoAb ACK-2 showed an identical pattern of c-kit expression among the cell lines, with the additional advantage of determining the number of receptor-positive cells in a population. Therefore, most subsequent studies on cell-surface c-kit expression were performed using indirect immunofluorescence analysis.
TGF-P inhibits SLF-driven growth of progenitor cell lines. TGF-P has been shown to be a potent inhibitor of SLF-mediated synergistic growth of lin-Sca-l+ cells, as well as more committed progenitors." To determine whether TGF-P could inhibit the proliferation of progenitors induced by SLF alone, the SLF-responsive MC-6 and FDC-P1 cell lines were incubated for 48 hours in the presence of saturating levels of SLF or IL-3 and increasing concentrations of TGF-P. The proliferative response of the cells was measured using 3[H]thymidine incorporation assays. TGF-P treatment resulted in a dose-dependent inhibition of SLF-driven proliferation of MC-6 cells ( Fig 1A) and FDC-P1 cells (Fig lC) , with half-maximal effect seen at approximately 0.04 to 0.06 ng/mL TGF-P. As previously demonstrated, and shown here for comparison, a similar pattern of dose-dependent growth inhibition by TGF-P was obtained using saturating concen- seen between 0.3 and 3 ng/mL TGF-P and maximal effect (50% inhibition) at 30 ng/mL (Fig 2A) . In a time-course study, greater than 50% inhibition of c-kit expression was observed after a 6-hour incubation of MC-6 cells with 20 ng/mL TGF-p, and this effect was maximal (64% inhibition) at 24 hours (Fig 2B) . Similar results were observed with the myeloid cell line FDC-PI. Specifically, 86% (84.8% 2 4.8%, n = 3) of the FDC-PI cells constitutively expressed c-kit.
Treatment of FDC-PI cells with 20 ng/mL TGF-P resulted in a time-dependent decrease in c-kit expression, with halfmaximal inhibition seen between 3 and 6 hours after TGFp treatment and maximal inhibition (60%) at 24 hours ( Fig   TGF-P regulates cell-srtrface c-kit expression by enriched bone marrow progenitors. To ascertain whether TGF-0 also modulates c-kit expression on primary bone marrow progenitors, purified progenitors were obtained by negative selection with immunomagnetic beads As previously demonstrated, the lin-population represents 5% of total BM cells and is enriched for multipotent and pluripotent hematopoietic progenitors (Keller et al. unpublished observation). Forty-two percent to 53% of lin-cells constitutively expressed c-kit at low and high intensity as determined by indirect immunofluorescence with the MoAb ACK-2, compared with 5% to 8% for total bone marrow cells".'; (Fig 3) . Treatment of the lin-population with TGF-P for 24 hours reduced the number of both low and high c-kit-expressing cells in a concentration-dependent fashion, with maximal inhibition seen at 3 ng/mL, where we found 20.6% of positive cells for the TGF-P-treated lin-population compared with 41.8% for control cells (Fig 3) .
TGF-P reduces the expression of c-kit mRNA in FDC-PI cells. To determine whether the observed inhibition of ckit cell-surface expression was a consequence of decreased levels of c-kit mRNA, we performed Northern blot analysis of total cellular RNA obtained from untreated and TGF-Ptreated FDC-PI cells. Autoradiography of the membranes showed a 5.5-kb signal upon probing with murine c-kit cDNA (Fig 4) . Treatment of the cells with TGF-P (20 ng/ mL) resulted in a decrease in c-kit mRNA level that was detected after 2 hours of incubation (21% reduction) and 2C).
was maximum after 6 hours (86% reduction). Similar inhibition was obtained with the pro-mastocyte cell line MC-6 (data not shown).
TGF-p affects c-kit mRNA stabilifl in FDCP l cells. To determine if the decrease in c-kit mRNA levels was related to changes in mRNA stability, FDC-PI cells were treated with TGF-P (20 ng/mL) for 6 hours. then actinomycin D (5 pg/mL) was added for various periods (30 minutes to 4 hours). Total RNA was extracted, probed with "P-labeled c-kit and GAPDH cDNAs, and the signals quantified by laser densitometric scanning. The results indicated that the level of c-kit mRNA in control cells progressively declined during actinomycin D treatment, with a half-life of approximately 2 to 4 hours (2.5 -+ 0.8 hours). Treatment of the cells with TGF-P resulted in a more rapid mRNA decay, with a calculated half-life of 0.5 to 1.5 hours ( I .O 2 0.5 hours) (Fig 5) . Such an increase in mRNA decay due to TGF-P treatment was consistently observed in all experiments performed (n = 3). Thus, TGF-P treatment reduced c-kit mRNA stability by more than twofold.
TGF-P inhibition qf c-kit expression is not due to changes in cell-cycle status. The addition of TGF-P to hematopoietic cells has been shown to arrest them in G, phase of the cell cycle.3" To delineate whether TGF-P modulates c-kit expression through the regulation of the cell cycle, TGF-Ptreated or control FDCPl cells were incubated in the presence of either nocodazole, a GdG, blocker,31 or the "S" blocker, aphidicolin." Flow cytometric data of a representative experiment indicated that 15 hours' treatment of FDCPl cells with 0.2 or 2 pg/mL nocodazole had no effect on the constitutive or TGF-p-induced inhibition of c-kit expression (Table 2) . Similar results were obtained using 0.2 or 2.0 pg/ mL aphidicolin. and the necessity of multiple growth factors to induce their gr~wth.~' Because the frequency of these cells in the total population is low, little is known about the mechanism(s) involved in the maintenance of the quiescent state. Using TGF-@-specific antisense nucleotides, a recent study demonstrated that autocrine production of TGF-@ may regulate the cycling of early progenitors and maintain these cells in G,JG,. 30 Our present findings of the inhibition of c-kit receptors, together with previously published data on the downmodulation of IL-1 and CSF receptors by TGF-P, suggest a common mechanism by which TGF-P would maintain progenitors in a nonresponsive or low-responsive state by reducing growth factor receptors below a threshold level. In fact, most recent findings indicate that the very primitive, slowly cycling, 5-fluorouracil-resistant progenitors are ckiflo. 38 Increased levels of positive growth factors during inf e c t i o n~~~ could likely ovemde TGF-P effects on hematopoietic growth factor receptors such as c-kit, resulting in the observed increase in hematopoietic cell production.
Multiple mechanisms can account for the observed downmodulation of c-kit by TGF-P, including modification of the affinity of preexisting receptors, changes in gene transcription and mRNA stability, and modifications in receptor trafficking. Attempts to study the affinity of the radiolabeled SLF for c-kit by equilibrium binding and Scatchard analysis have provided variable results due to a high level of receptor internalization even at 4"C, and in the presence of high concentrations of pharmaceuticals that block receptor internalization (eg, sodium azide).
On the other hand, treatment of progenitor cells with TGF-P is associated with a marked reduction in c-kit mRNA levels, which occurs, at least in part, at the posttranscriptional level. This was demonstrated by a more than twofold decrease in c-kit mRNA stability. Similar posttranscriptional regulation by IL-3 and GM-CSF has been reported for cfms, a tyrosine kinase membrane receptor for CSF-1.40 In addition, results from a recent report have demonstrated posttranscriptional regulation of c-kit expression in acute myeloid leukemia (AML) cells by TNF-CY.~' Even though processes that control c-kit mRNA stability are still mostly unknown, investigations of mRNA mechanisms have led to the identification of cis-acting structural determinants such as the AUUUA, motifs found in the 3' untranslated region of some growth factors and proto-oncogene ~R N A s . " ,~~ As shown in the published sequence, the 3' end of the murine c-kit mRNA has several copies of such AU-rich motif." It is therefore conceivable that TGF-P acts on c-kit mRNA degradation by inducing trans-acting factors that bind this sequence, resulting in cleavage and degradation of the message. Even though we show here a marked reduction of ckit mRNA stability by TGF-P, it remains possible that TGF-P also influences other regulatory checkpoints, such as mRNA synthesis.
The intensity of c-kit expression on adult bone marrow progenitor cells has been shown to decrease with maturation, with the more primitive lin-cells being c-kit-bright, whereas the committed lin+ population is c -k i t -d~l l .~~ It is unlikely that the decrease in c-kit expression mediated by TGF-P was due to changes in cell differentiation. Specifically, using a panel of MoAbs directed toward myeloid differentiation antigens, we have demonstrated that TGF-Pinduced modulation of other receptors' expression on progenitor cells was not associated with changes in differentiation.& Also, changes in receptor expression do not seem to be due to cell-cycle status, since the lin-progenitors investigated are not actively proliferating and are in the Go or G, phase of the cell cycle, and since TGF-P has been shown to act by arresting cells in the G, phase of the cell cycle. 30 In addition, results from this study using specific GdG,, as well as "S" blockers, strengthen the possibility that c-kit downmodulation by TGF-P is not a secondary event of cellcycle status.
In conclusion, our findings on the regulation of c-kit expression and responsiveness by TGF-P augment our understanding of the mechanism(s) between negative and positive regulators of normal hematopoiesis. The growth or lack of growth of early progenitor cells is regulated by (1) the synergy between growth factors, and ( 2 ) the balance between positive and negative signals. Since SLF is the most potent synergistic growth factor yet identified, the regulatory controls of its function would profoundly affect the growth and differentiation of these cells. The findings presented here, which indicate that TGF-P rapidly decreases the cell-surface expression of c-kit so that 50% of c-kit+ lin-bone marrow cells no longer express detectable c-kit, implicate receptor modulation as one of the mechanisms for control of progenitor cell growth.
